Seeing Is Believing
Currently out of the existing stock ratings of Shaunak Deepak, 10 are a BUY (100%).
Analyst Shaunak Deepak, Previously, Shaunak Deepak worked at JEFFERIES.
Shaunak Deepak’s has documented 16 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on KPTI, Karyopharm Therapeutics at 17-Mar-2017.
Analyst best performing recommendations are on MNKD (MANNKIND CORP).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Oct-2019
$8
$4.76 (146.91%)
$11
2 days ago
(27-Feb-2026)
2/11 (18.18%)
$4.76 (146.91%)
848
Buy Since 23-Jul-2025
$3.5
$0.26 (8.02%)
$7.5
2 days ago
(27-Feb-2026)
0/5 (0%)
$0.26 (8.02%)
Buy Since 19-Dec-2024
$9
$5.76 (177.78%)
$10
3 months 5 days ago
(24-Nov-2025)
0/2 (0%)
$3.87 (75.44%)
Buy Since 27-Feb-2023
$15
$11.76 (362.96%)
$12
5 months 24 days ago
(05-Sep-2025)
2/5 (40%)
$9.46 (170.76%)
384
Buy Since 10-Oct-2023
$15
$11.76 (362.96%)
$10
5 months 24 days ago
(05-Sep-2025)
0/2 (0%)
$9.46 (170.76%)
What Year was the first public recommendation made by Shaunak Deepak?